肝切除术后肝衰竭预测:肝细胞特异性对比剂MRI与吲哚菁绿清除试验比较
回顾性纳入2011至2013年73例因肝细胞癌行解剖性肝切除患者,测量钆塞酸二钠增强MRI肝胆期相对肝脏强化(RLE)与剩余肝细胞摄取指数(rHUI)等指标,并与未来残肝体积(FRLV)及吲哚菁绿(ICG)清除试验比较预测肝切除术后肝衰竭(PHLF)的效能。
要点
- 钆塞酸二钠增强MRI肝胆期定量指标RLE、rHUI及按体重校正的rHUI-BW可独立预测PHLF。
- rHUI与rHUI-BW的AUC大于RLE、ICG-PDR与FRLV,差异有统计学意义。
- MRI定量测量预测PHLF优于ICG清除试验。
核心结论
- 钆塞酸二钠增强MRI定量测量对肝细胞癌肝切除患者PHLF的预测优于ICG清除试验。
研究设计与样本
- 回顾性研究纳入2011至2013年73例因肝细胞癌行解剖性肝切除的患者,术前行钆塞酸二钠增强MRI并测量RLE与rHUI,FRLV由术前CT测量,并与ICG清除试验比较。
- 采用单因素与多因素分析寻找PHLF预测因素,并用ROC分析比较各预测指标的诊断效能。
关键影像表现/征象
- 利用肝胆期MR图像测量相对肝脏强化(RLE)与剩余肝细胞摄取指数(rHUI),并计算按体重校正的rHUI-BW,作为肝细胞功能的定量指标。
诊断标准与关键数值
- 73例中18例(25%)符合PHLF标准。
- 多因素分析显示RLE、FRLV、ICG-PDR、rHUI、rHUI-BW为PHLF的独立预测因素(p分别为0.011、0.034、0.003、p<0.001、0.001)。
- ROC分析中rHUI-BW的AUC大于RLE、ICG-PDR与FRLV(p分别为0.016、0.007、0.046);rHUI的AUC大于RLE与ICG-PDR(p分别为0.045、0.016)。
临床应用与阅片要点
- 作者认为,在肝细胞癌肝切除患者中,钆塞酸二钠增强MRI定量测量对PHLF的预测优于ICG清除试验。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective of our study was to identify whether quantitative measurements from gadoxetic acid-enhanced MRI are useful for predicting posthepatectomy liver failure (PHLF) in patients with hepatocellular carcinoma (HCC) compared with and in combination with future remnant liver volume (FRLV) and an indocyanine green (ICG) clearance test.
MATERIALS AND METHODS: Preoperative gadoxetic acid-enhanced MR images were retrospectively evaluated in 73 patients who underwent anatomic liver resection for HCC between 2011 and 2013. For quantitative measurement of hepatocyte function, relative liver enhancement (RLE) and remnant hepatocyte uptake index (rHUI) were measured using hepatobiliary phase MR images. FRLV was determined using measurements from preoperative CT scans. Univariate and multivariate analyses of measurements from gadoxetic acid-enhanced MRI, ICG clearance tests, and FRLV for finding predictors of PHLF were performed. To compare the diagnostic performance of predictors, ROC analyses were also performed.
RESULTS: Eighteen (25%) of 73 patients met the criteria for PHLF. Univariate analysis revealed that all measurements related to MRI including RLE, rHUI, ICG clearance, and FRLV were significantly associated with PHLF. Multivariate analysis showed that RLE, FRLV, ICG-plasma disappearance rate (ICG-PDR), rHUI, and rHUI corrected for body weight (rHUI-BW) were independent predictors of PHLF (p = 0.011, p = 0.034, p = 0.003, p < 0.001, and p = 0.001, respectively). In ROC analyses, AUCs of rHUI and rHUI-BW were larger than those of other independent predictors; the differences were statistically significant (for rHUI-BW vs RLE, ICG-PDR, and FRLV, p = 0.016, 0.007, and 0.046, respectively; for rHUI vs RLE and ICG-PDR, p = 0.045 and 0.016, respectively).
CONCLUSION: Measurements from gadoxetic acid-enhanced MRI predicted PHLF better than the ICG clearance test in patients with HCC who underwent hepatectomy.
引用
- Kim DK, Choi JI, Choi MH, et al. Prediction of Posthepatectomy Liver Failure: MRI With Hepatocyte-Specific Contrast Agent Versus Indocyanine Green Clearance Test. AJR Am J Roentgenol. 2018. PMID: 29995498. doi:10.2214/AJR.17.19206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。